Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Forsythe

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Child Welfare|January 1, 1984
A group model for adoption studies for special-needs childrenB J Forsythe, T W Marshall
Eye (London, England)|February 3, 2005
Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Phase I and II clinical trialsA B Tullo, B Esmaeli, P I Murray, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Child Welfare|January 1, 1984
A group model for adoption studies for special-needs childrenB J Forsythe, T W Marshall
Eye (London, England)|February 3, 2005
Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Phase I and II clinical trialsA B Tullo, B Esmaeli, P I Murray, et al.
Pageof 1